Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
78% of subjects maintained a clinically meaningful benefit of more than 3 points ... increase (venous hypertension). Symptoms of severe CVI include leg swelling, pain, edema, and in the most severe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback